+ All Categories
Home > Documents > Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80...

Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80...

Date post: 23-Mar-2020
Category:
Upload: others
View: 6 times
Download: 1 times
Share this document with a friend
26
Origins of Color Change in Biopharmaceuticals: Identification of Protein- and Excipient-Related Factors Alla Polozova Analytical Biochemistry Biopharmaceutical Development
Transcript
Page 1: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

Origins of Color Change in Biopharmaceuticals: Identification of Protein-and Excipient-Related Factors

Alla Polozova

Analytical Biochemistry

Biopharmaceutical Development

Page 2: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

2

Outline

Color measurements and standards

Expected color of intact proteins

Case studies: change in color of protein formulations during storage and stress studies– Case study 1: interaction of protein and excipients– Case study 2: protein-related factors

Page 3: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

3

Components of Color Assessment by Colorimetry

Light source:– white light is typically used for

measurementsTransmittance– will limit scope to clear solutions

Scale of spectral components– yellow-blue– red-green

D65 Day light spectrum

Identification of spectral components Transmittance spectra of colored solutions

Intensity scale

Page 4: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

4

Expected Color of Protein Solutions: Comparison of Transmittance Spectra of Yellow and Brown-Yellow Color Standards and a MAb at Different Concentrations

400 500 600 700

Wavelength, nm

20

40

60

80

100

Rel

ativ

e tr

ansm

ittan

ce, %

• Some color is expected in protein solutions, especially at higher concentrations• Transmittance patterns in concentrated MAb solutions are consistent with yellow or yellow-

brown color standards

0

20

40

60

80

100

350 450 550 650 750Wavelength, nm

Rel

ativ

e tra

nsm

ittan

ce, %

10 mg/mL50 mg/mL100 mg/mL150 mg/mL

Yellow EP color standards Y7-Y1

Non-stressed MAb solutions

Brown-yellow EP color standards BY7-Y1

Rel

ativ

e tr

ansm

ittan

ce, %

400 500 600 700

20

40

60

80

100

Page 5: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

5

Case study #1Change in color during

storage related to interaction of protein and excipients

Page 6: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

6

Case Study #1 Background

MAb A solution kept in polypropylene vials at 25 ºC turned dark brown upon several weeks of storage

Color was associated with the protein fraction, as shown by ultrafiltration and organic phase extraction

There was no detectable change in intact MAb A mass measured by MS

4oC25oC

Page 7: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

7

Analysis of Colored MAb A Solutions by Absorbance

MAB A stored at 4oC

MAB A stored at 25oC

Buffer control

• Presence of additional absorbance bands centered at 350 nm and 440 nmwas observed in colored MAb A solution

350 nm 440 nm

Page 8: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

8

Change in MAb A color and Aggregate Formation

• HPSEC analysis showed that change in color to darker brown correlated with increase in aggregates

• Aggregate fractions had higher absorbance at longer wavelengths (440 nm)• Color and aggregation were partially reversible upon cooing to 4 oC

dark brown color changed to light brown and aggregate level dropped 50%

2 4 6 8 10 12

mAU

0

200

400

600

800

1000

DAD1 A, Sig=280,10 Ref=off (Q:\LBDEVICE\11\DATA\PC81208JB000006.D)

2 4 6 8 10 12

mAU

0

200

400

600

800

1000

DAD1 A, Sig=280,10 Ref=off (Q:\LBDEVICE\11\DATA\PC81208JB000008.D)

2 4 6 8 10 12

mAU

0

200

400

600

800

1000

DAD1 A, Sig=280,10 Ref=off (Q:\LBDEVICE\11\DATA\PC81208JB000010.D)

2 4 6 8 10 12

mAU

0

200

400

600

800

1000

DAD1 A, Sig=280,10 Ref=off (Q:\LBDEVICE\11\DATA\PC81208JB000012.D)

Dark brown

Light brown

Colorless

280 nm MonomerAggregates

2 4 6 8 10

mAU

02.5

57.510

12.515

17.520

DAD1 B, Sig=440,10 Ref=off (Q:\LBDEVICE\11\DATA\PC81208JB000006.D)

DAD1 B Si 440 10 R f ff (Q \LBDEVICE\11\DATA\PC81208JB000008 D)

440 nmMonomer

Aggregates

HPSEC chromatograms

Brown

Page 9: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

9

Observations for Brown MAb A Samples and Maillard Reaction

MAb A formulation contained sugar and PS80

Brown samples had new absorbance bands at 350 nm and 440 nm

Brown sample contained high levels of partially reversibleaggregates

Brown samples had oily and sticky appearance

Maillard reaction:

Cross-linking reaction between proteins/peptides and sugars

Results in formation of brown melanoidin compounds

Initial cross-linking reaction steps (Schiff base, Amadori products) are reversible

Is it possible that brown substance in stressed MAb A samples was a product of Maillard reaction?

Page 10: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

10

Expected Hallmarks for Maillard Reaction

Presence of a reducing sugar– Presence of glucose was detected in brown-colored MAb A samples, but not in

controlsWhere did glucose come from? - Initial formulation contained non-reducing sugar

– PS-80 purity levels in brown MAb A samples were <50%– High level of peroxides were detected in brown MAb A solutions (~6-16 nM

compared to none in controls)– Possible reaction pathway:PS-80 degradation → peroxides → sugar oxidation → Maillard reaction*

Involvement of primary amines in the reaction– Level of Lys-containing peptides dropped as much as 75% in peptide map of brown

MAb A sampleIncrease in brown color with increase in high molecular weight products

Progressive increase in aggregate fraction correlated with increase in brown color

– Aggregates were partially reversible; dark brown color disappeared after aggregates dissociated

*Related published references:Hoffman, T., J. Agric. Food Chem. 46, 3891-5, 1998Nagaraj, R., et al., J. Biol. Chem. 271, 19338-45, 1996

Page 11: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

11

Case Study #1 Summary

Reversible increase in brown color was associated with increase in high molecular weight aggregates

PS-80 degradation and presence of peroxides correlated with oxidation of sugar in MAb A formulation

Significant loss of peptides with Lys residues was observed in peptide maps of brown samples

We speculate that oxidized sugar reacted with primary amines in MAb A as in Maillard reaction– Brown color was specifically associated with high molecular weight

aggregate fraction– Bridging melanoidin protein-sugar adducts are known to confer dark

brown color, larger aggregates have higher color intensity*

*Hoffman, T., J. Agric. Food Chem. 46, 3891-5, 1998

Page 12: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

12

Case Study #2

Change in color during photo stress accelerated stability studies

Page 13: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

13

Case Study # 2 Background

MAb B is an IgG formulated at 150 mg/mL

MAb B slightly brown-yellow color changed to brown under intense visual light during photostability study

During accelerated stability studies at higher temperature (25 oC for > 12 months) MAb B slightly yellow/yellow-brown color increased in intensity

Analysis was carried out to determine factors responsible for change in color of MAb B solutions

Page 14: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

14

Color of MAb B Samples Stressed by Intense Visual Light

Intense brown B1**Day 14

Intense brown yellow BY1*Day 4

Slightly brown yellow BY5*Initial

ColorTime point

Results of visual appearance test

Day 14 Day 4Initial

Color of MAb B samples stressed by intense visual light (9500 lux***), progressively changed from slightly brown-yellow to intense brown

* EP brown-yellow standard** EP brown standard*** Typical lab/office illumination is 400-1000 lux

Page 15: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

15

Change in MAb B Absorbance Pattern with Increased Exposure to Intense Visual Light

0.00

0.02

0.04

0.06

0.08

0.10

0.12

0.14

0.16

0.18

0.20

300 400 500 600 700 800

Wavelength, nm

Abs

orba

nce

InitialDay 1Day 2Day 4Day 7Day 10Day 14Day 14 (dark control)

Shoulder

430 nm

Exposure of MAb B to intense visual light resulted in increased absorbance at longer wavelengths:

Increase in shoulder between 310 and 390 nmNew band at ~430 nm

Page 16: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

16

RP-HPLC Analysis of Photo Stressed MAb B Samples

S a m p l e N a m e : C A T - 3 5 4 _ D E V 1 1 9 6 2 6 _ J F 2 1 S e p 1 2 D a t e A c q u ir e d : 9 / 2 2 / 2 0 1 2 1 0 : 0 5 : 1 9 A M E D T C h a n n e l D e s c r i p t i o n : A C Q U IT Y T U V C h A 2 8 0 n m S a m p l e N a m e : C A T - 3 5 4 _ D E V 1 1 9 6 4 2 _ J F 2 1 S e p 1 2 D a t e A c q u ir e d : 9 / 2 2 / 2 0 1 2 1 2 : 2 2 : 2 9 P M E D T C h a n n e l D e s c r i p t i o n : A C Q U IT Y T U V C h A 2 8 0 n m S a m p l e N a m e : C A T - 3 5 4 _ D E V 1 1 9 6 3 8 _ J F 2 1 S e p 1 2 D a t e A c q u ir e d : 9 / 2 2 / 2 0 1 2 1 : 0 8 : 1 8 P M E D T C h a n n e l D e s c r i p t i o n : A C Q U IT Y T U V C h A 2 8 0 n m S a m p l e N a m e : C A T - 3 5 4 _ D E V 1 1 9 6 5 2 _ J F 2 1 S e p 1 2 D a t e A c q u ir e d : 9 / 2 2 / 2 0 1 2 2 : 3 9 : 3 6 P M E D T C h a n n e l D e s c r i p t i o n : A C Q U IT Y T U V C h A 2 8 0 n m

AU

0 . 0 0

0 . 0 2

0 . 0 4

0 . 0 6

0 . 0 8

0 . 1 0

0 . 1 2

0 . 1 4

0 . 1 6

0 . 1 8

0 . 2 0

0 . 2 2

0 . 2 4

0 . 2 6

0 . 2 8

0 . 3 0

M in u t e s0 . 0 0 0 . 5 0 1 . 0 0 1 . 5 0 2 . 0 0 2 . 5 0 3 . 0 0 3 . 5 0 4 . 0 0 4 . 5 0 5 . 0 0 5 . 5 0 6 . 0 0 6 . 5 0 7 .0 0

AU

-0.0010

-0.0005

0.0000

0.0005

0.0010

0.0015

0.0020

0.0025

0.0030

0.0035

0.0040

Minutes0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00

Day 14

Initial

Day 4

280 nm

330 nm

Day 7

• Analysis of RP-HPLC profiles showed that species absorbing at longer wavelengths were associated with protein

• Longer light exposure correlated with increased absorbance at longer wavelengths

Initial

Day 4

Day 7

Day 14

Absorbance spectra of individual peaks

Day 14Day 4

Day 7

Initial

Page 17: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

17

Peptide Mapping Profiles of Mab A Samples Exposed to Intense Visual Light for 14 Days

min10 20 30 40 50 60 70

mAU

0

5

10

15

20

25

DAD1 B, Sig=290,4 Ref=500,40 (JF2012092722C\JF2012092722C13.D)

min*10 20 30 40 50 60 70

mAU

0

5

10

15

20

25

*DAD1 B, Sig=290,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min10 20 30 40 50 60 70

mAU

0

1

2

3

4

DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C13.D)

min*10 20 30 40 50 60 70

mAU

0

1

2

3

4

*DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

M Oxi

Initial

Day14

Initial (dark control was similar)

Day14

H Oxi

W Oxi

W Oxi W Oxi

• Multiple oxidation products were identified (M, H & W)

• Only peptides containing oxidized W were detectable at 355 nm absorbance

H Oxi

355 nm

220 nm

220 nm

355 nm

Page 18: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

18

min10 11 12 13 14

mAU

0

50

100

DAD1 A, Sig=220,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min10 11 12 13 14

mAU

0

2

4

DAD1 B, Sig=290,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min10 11 12 13 14

mAU

0.250.5

0.75

DAD1 D, Sig=310,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min10 11 12 13 14

mAU

0.51

1.5

DAD1 E, Sig=330,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min10 11 12 13 14

mAU

0123

DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

355 nm

H9+32Da

Hx+4Da

Intact peptide Hx

330 nm

310 nm

290 nm

220 nm

Hx +32DaHx +16Da Hx +4Da

Hx+4Da

Multiple Oxidation Forms of One of the Peptides in Peptide Map of MAb B Sample Exposed to Intense Visual Light for 14 Days

Three different W oxidation forms of peptide Hx have different absorbance properties

Page 19: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

19

Absorbance Spectra of Three Detected W Oxidation Forms of Peptide Hx in Peptide Map Of Photo Stressed MAb B

DAD1, 11.787 (23.7 mAU, - ) of JF2012092722C10.DDAD1, 11.967 (6.6 mAU, - ) of JF2012092722C10.DDAD1, 14.154 (60.1 mAU, - ) of JF2012092722C10.D

nm250 300 350 400 450

DAD1, 10.800 (23.5 mAU, - ) of JF2012092722C10.D

Intact HxHx +16DaHx +32DaHx +4Da

• Individual W oxidized forms have different absorbance properties

• All oxidized forms show shift to longer wavelengths, some of them to greater extent, with +4 Da form exhibiting the biggest red shift

Page 20: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

20

Time-Dependent Accumulation of Major Oxidized Tryptophan Species of MAb B Peptide Hx

+16Da +32Da +4Da

Known W oxidation pathways

• Larger amounts of W oxidation forms absorbing at longer wavelengths accumulate with prolonged MAb B exposure to intense visual light

• Accumulation of these W oxidation products correlates with change in color to more intense yellow and brown

Peptide H9 Oxidation Distribution

0.0

5.0

10.0

15.0

20.0

25.0

0 2 4 6 8 10 12 14

Light Exposure Time (Day)

% O

xida

tion

H9(W104+4Da,11.6 min)

H9(W104+16Da,10.6 min)

H9(W104+32Da,11.8 min)

Different W oxidation forms in peptide Hx

Hx+4 Da

Hx+16 Da

Hx+32 Da

Page 21: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

21

Comparison of Visual Light Absorbing Species in Photo Stressed and Heat Stressed MAb B Samples

min10 20 30 40 50 60 70

mAU

0

1

2

3

4

DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C12.D)

min10 20 30 40 50 60 70

mAU

0

1

2

3

4

DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C10.D)

min*10 20 30 40 50 60 70

mAU

0

1

2

3

4

*DAD1 F, Sig=355,4 Ref=500,40 (JF2012092722C\JF2012092722C11.D)

Day14 photo stress

Accelerated stability

(+25 oC for > 12 months)

W oxi

W Oxi2W Oxi

W Oxi

Initial (dark control was similar)

W Oxi

• In both photo- and heat-stressed samples only oxidized W species were responsible for absorbance in visual spectrum

• Some differences in location of oxidized W were observed for heat-stressed MAb B

355 nm

355 nm

355 nm

Page 22: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

22

Case 2 Study Summary

Photo degradation of MAb B under intense visual light results inoxidation of multiple Met, Trp and His residues

Only Trp oxidation products have absorbance in visual spectrum contributing to MAb B color

Multiple Trp oxidation forms with different absorbance properties are present – Accumulation of forms absorbing at longer wavelengths correlates with

change in MAb B color to brown after longer exposure to intense visual light

Similar factors were responsible for change in color intensity in heat stressed MAb B– Differences in location of Trp residues susceptible to oxidation,

compared to photo stressed MAb B, were observed

Page 23: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

23

Conclusions

Proteins are expected to exhibit some color, especially in highly concentrated solutions

Multiple factors can lead to change in color during storage and accelerated stability studies:– Interaction of protein and excipients influenced by environmental factors

(exposure to oxidants and light)– Accumulation Trp oxidation products can lead to increase in color

intensity and change to brown color

Page 24: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

24

Acknowledgements

Jose Casas-Finet

Jenny Feng

Flaviu Gruia

Arun Parupudi

Hung-Yu Lin

Sophia Levitskaya

Methal Albarghouthi

Yiming Li

Chris Barton

Bob Strouse

Mike Washabaugh

Pat Cash

Mark Schenerman

Page 25: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

25

Back up slide

Page 26: Origins of Color Change in Biopharmaceuticals ... · – Possible reaction pathway: PS-80 degradation →peroxides →sugar oxidation →Maillard reaction* Involvement of primary

26

Correlation between Color Change and Potency Loss in MAb B Case Study

0

20

40

60

80

100

120

0 2 4 6 8 10 12 14

Time (days)

%

% Trp oxidation

% Potency

% Transmittance at 430 nmSlightly

brown-yellow

Intense brown-yellow

Intense brown

• Change in MAb B color to intense brown correlated with potency loss• Trp oxidation responsible for color change was a contributing factors to

potency loss, but not the only one


Recommended